Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans.

Abstract:

:Diaspirin cross-linked hemoglobin (DCLHb) is an intramolecularly cross-linked hemoglobin-based oxygen carrier being developed as a therapy for acute blood loss. We report here the absence of immunogenicity of DCLHb in patients enrolled in phase II and III clinical trials of DCLHb. Two very sensitive immunoassays, an enzyme-linked immunosorbent assay (ELISA) and a Western blot assay, were developed and validated for this assessment. The DCLHb-antibodies used in these assays were raised in monkeys, had similar affinities for DCLHb and native human hemoglobin (SFHb), and showed cross-reactivity for subunits of DCLHb and SFHb on the Western blot, suggesting that these antibodies were elicited as a xenogenic response to the protein. In the ELISA, the optical density of a patient sample exposed to DCLHb-coated wells was compared with that of the patient sample exposed to carbonate buffer-coated wells; an optical density ratio of 1.4 was established for discriminating between a positive (reactive) or negative DCLHb antibody response. To date, all of the more than 300 patient specimens (preinfusion and postinfusion) from clinical trials have exhibited a ratio of less than 1.4, confirming the lack of preexisting antibodies to DCLHb and clearly showing the absence of DCLHb antibodies after exposure to this new biologic entity. There has been no requirement for use of the confirmatory Western blot assay. Taken together, the results from this study indicate DCLHb is not immunogenic in humans at doses evaluated clinically.

journal_name

Blood

journal_title

Blood

authors

Patel MJ,Webb EJ,Shelbourn TE,Mattia-Goldberg C,George AJ,Zhang F,Moore EG,Nelson DJ

subject

Has Abstract

pub_date

1998-01-15 00:00:00

pages

710-6

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

91

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.

    abstract::Human ADAMTS13 is a multidomain protein with metalloprotease (M), disintegrin-like (D), thrombospondin-1 (T), Cys-rich (C), and spacer (S) domains, followed by 7 additional T domains and 2 CUB (complement components C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains. ADAMTS13 inhibits the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-11-886309

    authors: Zhu J,Muia J,Gupta G,Westfield LA,Vanhoorelbeke K,Tolia NH,Sadler JE

    更新日期:2019-04-25 00:00:00

  • Cellular response to hypoxia involves signaling via Smad proteins.

    abstract::The transforming growth factor-beta (TGF-beta) family of cytokines regulates vascular development and inflammatory responses. We have recently shown that exposure of human umbilical vein endothelial cells (HUVECs) to hypoxia (1% O(2)) increases gene expression and bioactivation of TGF-beta2 and induces its downstream ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-02-0629

    authors: Zhang H,Akman HO,Smith EL,Zhao J,Murphy-Ullrich JE,Batuman OA

    更新日期:2003-03-15 00:00:00

  • A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

    abstract::Donor lymphocyte infusions (DLIs) induce potent graft versus tumor (GVT) effects for relapsed chronic myelogenous leukemia (CML) after allogeneic stem cell transplantation (SCT) but are disappointing for other diseases. Disease resistance can occur if donor T cells are not appropriately activated in vivo. Ex vivo T-ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-08-3373

    authors: Porter DL,Levine BL,Bunin N,Stadtmauer EA,Luger SM,Goldstein S,Loren A,Phillips J,Nasta S,Perl A,Schuster S,Tsai D,Sohal A,Veloso E,Emerson S,June CH

    更新日期:2006-02-15 00:00:00

  • Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation.

    abstract::The engraftment of donor bone marrow (BM) cells in nonablated mice is inefficient. Niche availability has been thought to be the reason, and cytoablation with irradiation or cytotoxic agents is routinely used with the belief that this frees the preoccupied niches in recipients. In this study, donor cell redistribution...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-04-1256

    authors: Zhong JF,Zhan Y,Anderson WF,Zhao Y

    更新日期:2002-11-15 00:00:00

  • Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.

    abstract::Blockade of the CD40/CD154 signal is a potential immunomodulatory strategy for T-cell-mediated diseases. As a part of a phase 1, multicenter, dose-escalating trial of humanized monoclonal antibody to CD154 (IDEC-131/E6040) in patients with refractory immune thrombocytopenic purpura (ITP), the autoimmune response to gl...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2003-06-2167

    authors: Kuwana M,Nomura S,Fujimura K,Nagasawa T,Muto Y,Kurata Y,Tanaka S,Ikeda Y

    更新日期:2004-02-15 00:00:00

  • Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells.

    abstract::Thymosin beta 4 (T beta 4) was originally isolated as a thymic hormone. Its functional properties remain obscure; however, the N-terminal peptidic sequence could have a regulatory function on hematopoietic stem cell proliferation. To investigate the mechanism of T beta 4 expression, we studied T beta 4 gene expression...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shimamura R,Kudo J,Kondo H,Dohmen K,Gondo H,Okamura S,Ishibashi H,Niho Y

    更新日期:1990-09-01 00:00:00

  • Transfusion-associated AIDS: donor-recipient human immunodeficiency virus exhibits genetic heterogeneity.

    abstract::The genetic diversity of the human immunodeficiency virus (HIV) isolated from transfusion-associated AIDS patients has been examined. Restriction enzyme mapping studies of integrated proviral DNA of donor and recipient origin demonstrated genomic variation between isolates. Analysis of the molecularly cloned viral gen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Srinivasan A,York D,Ranganathan P,Ferguson R,Butler D Jr,Feorino P,Kalyanaraman V,Jaffe H,Curran J,Anand R

    更新日期:1987-06-01 00:00:00

  • How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).

    abstract::Indolent systemic mastocytosis (SM) patients have a varied clinical presentation, ranging from predominantly cutaneous symptoms to recurrent systemic symptoms (eg, flushing, palpitations, dyspepsia, diarrhea, bone pain) that can be severe and potentially life threatening (anaphylaxis). Mastocytosis patients without sk...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-453183

    authors: Pardanani A

    更新日期:2013-04-18 00:00:00

  • CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.

    abstract::Gemtuzumab ozogamicin (GO) contains an anti-CD33 antibody to facilitate uptake of a toxic calicheamicin-gamma(1) derivative. While recent in vitro data demonstrated a quantitative relationship between CD33 expression and GO cytotoxicity, previous correlative studies failed to identify a significant association between...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047399

    authors: Walter RB,Gooley TA,van der Velden VH,Loken MR,van Dongen JJ,Flowers DA,Bernstein ID,Appelbaum FR

    更新日期:2007-05-15 00:00:00

  • Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

    abstract::Treatment outcome of acute myeloid leukemia (AML) in elderly patients remains unsatisfactory. It has been shown that the infusion of granulocyte colony-stimulating factor-mobilized donor peripheral blood stem cells (G-PBSCs) can enhance graft-versus-leukemia effects and speed hematopoietic recovery. Fifty-eight AML pa...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-06-288506

    authors: Guo M,Hu KX,Yu CL,Sun QY,Qiao JH,Wang DH,Liu GX,Sun WJ,Wei L,Sun XD,Huang YJ,Qiao JX,Dong Z,Ai HS

    更新日期:2011-01-20 00:00:00

  • Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.

    abstract::Recent evidence suggests chronic myeloid leukemia (CML) stem cells are insensitive to kinase inhibitors and responsible for minimal residual disease in treated patients. We investigated whether CML stem cells, in a transgenic mouse model of CML-like disease or derived from patients, are dependent on Bcr-Abl. In the tr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-326843

    authors: Hamilton A,Helgason GV,Schemionek M,Zhang B,Myssina S,Allan EK,Nicolini FE,Müller-Tidow C,Bhatia R,Brunton VG,Koschmieder S,Holyoake TL

    更新日期:2012-02-09 00:00:00

  • Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting.

    abstract::Interleukin-3 (IL-3) is involved in proliferation and differentiation of hematopoietic progenitor cells. Its expression is subject to precise, tissue-specific regulation, and has been studied extensively in the gibbon T-cell line MLA 144 by a combination of functional assays and DNA binding experiments. To extend thes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cameron S,Taylor DS,TePas EC,Speck NA,Mathey-Prevot B

    更新日期:1994-05-15 00:00:00

  • Pre-TCR expression cooperates with TEL-JAK2 to transform immature thymocytes and induce T-cell leukemia.

    abstract::The TEL-JAK2 gene fusion, which has been identified in human leukemia, encodes a chimeric protein endowed with constitutive tyrosine kinase activity. TEL-JAK2 transgenic expression in the mouse lymphoid lineage results in fatal and rapid T-cell leukemia/lymphoma. In the present report we show that T-cell leukemic cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-048801

    authors: dos Santos NR,Rickman DS,de Reynies A,Cormier F,Williame M,Blanchard C,Stern MH,Ghysdael J

    更新日期:2007-05-01 00:00:00

  • Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

    abstract::The human peripheral B-cell compartment displays a large population of immunoglobulin M-positive, immunoglobulin D-positive CD27(+) (IgM(+)IgD(+)CD27(+)) "memory" B cells carrying a mutated immunoglobulin receptor. By means of phenotypic analysis, complementarity-determining region 3 (CDR3) spectratyping during a T-in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0346

    authors: Weller S,Braun MC,Tan BK,Rosenwald A,Cordier C,Conley ME,Plebani A,Kumararatne DS,Bonnet D,Tournilhac O,Tchernia G,Steiniger B,Staudt LM,Casanova JL,Reynaud CA,Weill JC

    更新日期:2004-12-01 00:00:00

  • Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies.

    abstract::Interleukin-3 (IL-3) has been shown to be a promising agent in the stimulation of bone marrow regeneration following myeloablative therapy. The biologic half-life of this agent is very short (5 to 15 minutes), which limits the effectiveness of low-dose therapy. Here we show that the biologic effects of low-dose IL-3 i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones AT,Ziltener HJ

    更新日期:1993-08-15 00:00:00

  • Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha.

    abstract::A new human leukemia cell line, KT-1, was established from a patient in the blastic crisis phase of chronic myelogenous leukemia (CML). This cell line had a positive reaction for intracytoplasmic myeloperoxidase and two Philadelphia chromosomes (Ph1) [t(9;22)(q34;q11)] and lacked normal copies of chromosomes 9 and 22....

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yanagisawa K,Yamauchi H,Kaneko M,Kohno H,Hasegawa H,Fujita S

    更新日期:1998-01-15 00:00:00

  • Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

    abstract::Hematide is an investigational pegylated synthetic peptide that stimulates erythropoiesis in animal models and is being developed for the treatment of anemia associated with chronic renal failure and cancer. This study evaluated the safety and pharmacodynamics of single, intravenous doses (0.025, 0.05, and 0.1 mg/kg) ...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2006-04-015818

    authors: Stead RB,Lambert J,Wessels D,Iwashita JS,Leuther KK,Woodburn KW,Schatz PJ,Okamoto DM,Naso R,Duliege AM

    更新日期:2006-09-15 00:00:00

  • Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces.

    abstract::Fibronectin (FN) plays a role in several adhesion mediated functions including the interaction of platelets with subendothelium. We investigated the role of plasma FN in platelet adhesion and platelet thrombus formation under flow conditions. We used two different perfusion models: the annular chamber with alpha-chymo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bastida E,Escolar G,Ordinas A,Sixma JJ

    更新日期:1987-11-01 00:00:00

  • Interaction between FXIII and fibrinogen.

    abstract::In this issue of Blood, Smith and colleagues report on the functional role of the interaction between these 2 proteins by studying the involved binding sites responsible for clot stabilization.(1) ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-01-479055

    authors: Kohler HP

    更新日期:2013-03-14 00:00:00

  • Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.

    abstract::The plasminogen activator inhibitor PAI-1 is markedly elevated in vivo and in vitro upon exposure to the inflammatory mediators tumor necrosis factor alpha (TNF alpha), interleukin-1 (IL-1), and bacterial lipopolysaccharide. Here we report that the isoflavone compound genistein prevents the increase in synthesis of PA...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Hinsbergh VW,Vermeer M,Koolwijk P,Grimbergen J,Kooistra T

    更新日期:1994-11-01 00:00:00

  • The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin.

    abstract::The interaction of thrombin with plasminogen activator inhibitor 1 (PAI-1) is shown to result in the simultaneous formation of both cleaved PAI-1 and a sodium dodecyl sulfate-stable thrombin-PAI-1 complex. The kinetics of this reaction can be described by a "suicide substrate" mechanism that includes a branched reacti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Meijer M,Smilde A,Tans G,Nesheim ME,Pannekoek H,Horrevoets AJ

    更新日期:1997-09-01 00:00:00

  • Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL.

    abstract::Patients aged ≥60 years with treatment-naive Hodgkin lymphoma (HL) have few treatment options and inferior survival due to treatment-related toxicities and comorbidities. This phase 2, nonrandomized, open-label study evaluated brentuximab vedotin (BV) monotherapy (results previously reported), BV plus dacarbazine (DTI...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-787200

    authors: Friedberg JW,Forero-Torres A,Bordoni RE,Cline VJM,Patel Donnelly D,Flynn PJ,Olsen G,Chen R,Fong A,Wang Y,Yasenchak CA

    更新日期:2017-12-28 00:00:00

  • MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells.

    abstract::IL-12 exerts several regulatory effects on natural killer (NK) cells by activating IL-12 signaling. IL-12 signaling is tightly auto-regulated to control its onset and termination, with prolonged IL-12 treatment resulting in IL-12 hyporesponsiveness. However, the mechanisms underlying IL-12 auto-regulation are still un...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-356162

    authors: Huang Y,Lei Y,Zhang H,Hou L,Zhang M,Dayton AI

    更新日期:2011-12-22 00:00:00

  • Role of arginine residues in the coagulant activity of high molecular weight kininogen.

    abstract::High molecular weight (HMW) kininogen, the cofactor for activation of the contact system of plasma proteolysis, transports and optimally positions prekallikrein and factor XI on a negatively charged surface, allowing those zymogens to be activated by surface-bound factor XIIa. HMW kininogen circulates in plasma as a p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chang JJ,Scott CF,Colman RW

    更新日期:1986-03-01 00:00:00

  • Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1.

    abstract::Biologic responses to cytokines are mediated by intracellular pathways involving induction of signaling and metabolic cascades. Interferon (IFN) regulatory factor-1 (IRF-1) is a major transcription factor induced not only by IFN-gamma but also by other cytokines including tumor necrosis factor-alpha (TNF-alpha). Possi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sato T,Selleri C,Young NS,Maciejewski JP

    更新日期:1995-11-01 00:00:00

  • Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.

    abstract::Chronic lymphocytic leukemia of B-cell origin (B-CLL) is generally thought to arise by neoplastic transformation of B lymphocytes, which express CD5 and have features of an early stage of B-cell differentiation. To study isotype-switched B-CLL as a potentially more differentiated variant, we performed genetic and func...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Friedman DF,Moore JS,Erikson J,Manz J,Goldman J,Nowell PC,Silberstein LE

    更新日期:1992-11-01 00:00:00

  • A new cytokine-dependent monoblastic cell line with t(9;11)(p22;q23) differentiates to macrophages with macrophage colony-stimulating factor (M-CSF) and to osteoclast-like cells with M-CSF and interleukin-4.

    abstract::Monocytes/macrophages exert a series of important functions in vivo. To facilitate detailed investigation of their functional capacity and the mechanism leading to their differentiation, several cell lines have been established from primary material. We present here a new human monoblastic cell line, designated UG3. U...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ikeda T,Sasaki K,Ikeda K,Yamaoka G,Kawanishi K,Kawachi Y,Uchida T,Takahara J,Irino S

    更新日期:1998-06-15 00:00:00

  • Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations.

    abstract::The anemia of chronic disease (ACD) results from 3 major processes: slightly shortened red cell survival, impaired reticuloendothelial system iron mobilization, and impaired erythropoiesis. Hepcidin is an acute-phase protein with specific iron regulatory properties, which, along with the anemia seen with increased hep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2854

    authors: Dallalio G,Law E,Means RT Jr

    更新日期:2006-04-01 00:00:00

  • Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides.

    abstract::We investigated the correlation between the detection of clonal rearrangement of the T-cell antigen receptor gene (TCRR) in lymph node tissue with histopathologic lymph node classification in 33 patients with mycosis fungoides with and without the Sezary Syndrome. We analyzed DNA extracted from lymph nodes that were h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lynch JW Jr,Linoilla I,Sausville EA,Steinberg SM,Ghosh BC,Nguyen DT,Schechter GP,Fischmann AB,Ihde DC,Stocker JL

    更新日期:1992-06-15 00:00:00

  • The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor.

    abstract::A plethora of myeloma growth factors (MGFs) has been identified, but their relative importance and cooperation have not been determined. We investigated 5 MGFs (interleukin-6 [IL-6], insulin-like growth factor type 1 [IGF-1], hepatocyte growth factor [HGF], HB-epidermal growth factor [HB-EGF], and a proliferation-indu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-170464

    authors: Sprynski AC,Hose D,Caillot L,Réme T,Shaughnessy JD Jr,Barlogie B,Seckinger A,Moreaux J,Hundemer M,Jourdan M,Meissner T,Jauch A,Mahtouk K,Kassambara A,Bertsch U,Rossi JF,Goldschmidt H,Klein B

    更新日期:2009-05-07 00:00:00